National Health Research Institutes, Taiwan

This study compares two experimental drug combinations for people with metastatic pancreatic cancer that has spread. The goal is to see which combo works better at shrinking tumors and delaying cancer growth. About 66 adults who have not had chemotherapy for their advanced cancer…

This study tests a combination of two drugs (atezolizumab and bevacizumab) in people with advanced liver cancer who also have chronic hepatitis B. The goal is to see if the treatment can shrink or control the cancer. Participants receive the drugs by IV and are monitored for side…

This study tests a combination of two drugs, lenvatinib and paclitaxel, in people with advanced bile duct cancer that has stopped responding to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. About 51 adults with various types of…

This study looks at the genetic makeup of a rare type of gastrointestinal stromal tumor (GIST) that does not have the usual c-KIT or PDGFRA mutations. Researchers want to understand what other genetic changes might be driving these tumors in Taiwanese patients. The goal is to fin…

This study aims to collect and analyze tumor tissue from 480 people in Taiwan with advanced biliary tract cancer. By looking at the genetic makeup of each tumor, researchers hope to find specific changes that could be targeted with existing or new drugs. The goal is to create a d…